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The PHD Finger of the Chromatin-Associated
Protein ING2 Functions as a Nuclear
Phosphoinositide Receptor
proteins bind in vitro to PtdInsPs, including the rare
PtdInsP species, phosphatidylinositol 5-phosphate
(PtdIns(5)P). Further, we demonstrate that the ING2
PHD finger interacts with PtdIns(5)P in vivo and pro-
vide evidence that this interaction regulates the ability
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Summary as in the cytoplasm. However, the specific mechanisms
of nuclear PtdInsP signaling have been difficult to eluci-
Phosphoinositides (PtdInsPs) play critical roles in cyto- date, primarily due to the absence of known nuclear
plasmic signal transduction pathways. However, their PtdInsP binding domains.
functions in the nucleus are unclear, as specific nu- The PHD motif is a conserved Cys4-HisCys3 orphan
clear receptors for PtdInsPs have not been identified. zinc finger domain present throughout eukaryotic pro-
Here, we show that ING2, a candidate tumor suppres- teomes (Aasland et al., 1995). A large number of chroma-
sor protein, is a nuclear PtdInsP receptor. ING2 con- tin regulatory factors contain PHD fingers, including the
tains a plant homeodomain (PHD) finger, a motif com- acetyltransferase proteins CBP/p300, the chromatin re-
mon to many chromatin-regulatory proteins. We find modeling protein ACF, and the ING family of putative
that the PHD fingers of ING2 and other diverse nuclear tumor suppressors (Feng et al., 2002; Fyodorov and
Kadonaga, 2002; Kalkhoven et al., 2002). Mutations
within PHD fingers are found in tumor tissue and result*Correspondence: jyuan@hms.harvard.edu
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Cell
100
et al., 2000). Recently, a subclass of putative PHD fingers We confirmed these results by independent methods
for detecting PtdInsP-protein interactions. Surface plas-were shown to have E3-ubiquitin ligase activity, but
mon-resonance (SPR) biosensor analysis revealed thatother analyses indicate these modules are in fact RING
ING2(PHD) interacted with liposomes containing PtdIns(5)Pfinger variants (Aravind et al., 2003). Regardless, the
and PtdIns(3)P, but not with PtdIns(4)P or control lipo-PHD finger has been proposed to function in either pro-
somes (Figure 1D). Additionally, using different PtdInsP-tein-protein or protein-DNA interactions; however, a
coupled affinity resins, we found that in vitro translatedphysiologic PHD binding partner has not been identified
(IVT) ING2(PHD) bound specifically to PtdIns(5)P (Figure(Aasland et al., 1995).
1E). As controls, the PtdIns(3)P and PtdIns(3,4,5)P3 affin-The ING family is conserved from yeast to humans
ity resins bound to their known protein interactors,and members of this family associate with and modulate
p40(PX) and PHISH/DAPP1, respectively (Figure 1E) (Ell-the activity of histone acetyl transferase (HAT) and his-
son et al., 2001; Rao et al., 1999). Thus, the ING2 PHDtone deacetylase (HDAC) complexes (Feng et al., 2002).
finger was detected interacting with PtdInsPs by threeBoth ING1 and ING2 cooperate with the tumor suppres-
independent in vitro methods.sor p53 to induce cellular growth arrest and apoptosis,
To quantify the relative affinity of ING2 for PtdInsPs,and ING2 overexpression stimulates acetylation of p53
we probed a lipid blot with serial dilutions of eight differ-(Garkavtsev et al., 1998; Nagashima et al., 2001). Thus,
ent PtdInsPs (Figure 1F). Full-length ING2 and ING2(PHD)the ING family appears to link chromatin regulation with
bound most tightly to PtdIns(5)P and PtdIns(3)P (Figurep53 function and tumor suppression, though the bio-
1F). The caspase-5 fusion protein did not bind to anychemical function of these proteins has not been estab-
phospholipid, and PIKII bound most tightly tolished.
PtdIns(3)P, PtdIns(3,4)P2, and PtdIns(5)P, consistentIn this study, we identify ING2 as a PtdInsP-interacting
with its reported substrate activity (Figure 1F) (Ramehpartner. Further, we show that the PHD fingers of ING2
et al., 1997; Zhang et al., 1997).and other diverse nuclear proteins bind to PtdInsPs. We
The PHD finger is an interlaced zinc binding motifalso find that PtdInsPs modulate both the localization
(Capili et al., 2001; Pascual et al., 2000). We found thatand activity of endogenous ING2. Thus, we identify the
the zinc chelator, TPEN, specifically decreased bindingPHD finger as a nuclear receptor of PtdInsP signaling.
of ING2 and ING2(PHD) to PtdIns(5)P and PtdIns(3)P by
nearly an order of magnitude, but had no effect onResults
PtdInsP-PHISH/DAPP1 interactions (Figure 1F). In addi-
tion, a derivative of the PHD finger (ING2(PHD-Znmt)) withThe PHD Finger of ING2 Binds
mutations in the zinc-coordinating residues bound onlyto Phosphoinositides In Vitro
weakly to PtdInsPs in the absence or presence of TPENTo identify novel downstream targets of PtdInsPs, a
(Figure 1F). Thus, zinc coordination by the PHD motif issmall pool library expression screen was carried out
necessary for ING2(PHD)-PtdInsP interactions.with a PtdInsP-affinity resin (Figure 1A) (Rao et al., 1999).
This strategy identified ING2 as a candidate PtdInsP
Structural Model of the ING2 PHDbinding protein (Figure 1B) (Shimada et al., 1998). In a
Finger-PtdInsP Complex
protein-lipid blot assay (Dowler et al., 2002), a GST-ING2
The NMR solution structure of the PHD finger of the
fusion protein interacted most strongly with PtdIns(5)P,
WSTF protein revealed that this domain is structurally
which, to our knowledge, has no previously demon- similar to the FYVE finger (Misra et al., 2001; Pascual et
strated protein module binding partner (Figure 1B). al., 2000). To gain insight into the structural basis of the
ING2 contains a PHD finger (Figure 1B). As this module ING2 PHD finger-PtdInsP complex, a model of the ING2
is structurally similar to the FYVE-finger, a known PHD finger was built based on known PHD finger solu-
PtdIns(3)P binding module (Pascual et al., 2000; Sten- tion structures (Capili et al., 2001; Pascual et al., 2000)
mark et al., 2002), we asked whether the PHD finger of and superimposed onto the known structure of the FYVE
ING2 mediates the ING2-PtdInsP interaction. As shown finger-PtdIns(3)P complex (Figure 2A) (Kutateladze and
in Figure 1C, a GST fusion of the PHD finger of ING2 Overduin, 2001). We focused our attention on basic resi-
(ING2(PHD)) is sufficient for binding PtdIns(5)P. dues within the PHD finger of ING2, as such residues
To control for the quality of the lipid blots, we used are predicted to interact with the acidic head group of
various protein domains that interact with different PtdInsPs. The structural alignment revealed three lysine
PtdInsP species as probes. As shown in Figure 1C, the residues that form a positively charged patch on the
PX domain of p40Phox (p40(PX)), PH (pleckstrin homol- surface of the ING2 PHD finger (Figure 2A, red residues)
ogy) domain of FAPP1 (FAPP1(PH)), and PHISH/DAPP1 and map close to four arginine residues (Figure 2A, blue
bound to their known PtdIns(P) targets (PtdIns(3)P, residues) that are part of the PtdInsP binding surface
PtdIns(4)P, PtdIns(3,4)P2, respectively) (Dowler et al., of the FYVE finger (Kutateladze and Overduin, 2001).
2000; Ellson et al., 2001). To control for PtdIns(5)P inter- Two other basic residues (Figure 2A, green residues
actions, we used the lipid kinase PIKII, which phos- [K58, R60]) are located on a different face of the ING2
phorylates PtdIns(5)P to generate PtdIns(4,5)P2 (Rameh PHD finger. Finally, a stretch of basic residues is present
et al., 1997). PIKII detected PtdIns(5)P (as well as at the very end of the ING2 PHD finger (see Figure 2E,
PtdIns(3)P and PtdIns(3,4)P2, its other in vitro substrates blue residues), but these could not be modeled because
(Zhang et al., 1997)) in the lipid blot assay (Figures 1C the solved structures of other PHD fingers do not extend
and 1F). As negative controls, GST alone, caspase-5, into this region. Thus, the PHD finger of ING2 has three
and a derivative of ING2 lacking the PHD finger (ING2(1–40)) distinct regions that contain basic residues that may
participate in PtdInsP binding.did not bind to any PtdInsPs (Figures 1B and 1C).
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Figure 1. Identification of the ING2 PHD Finger as a PtdInsP Binding Module
(A) Small pool expression screen to identify PtdInsP binding proteins. 35S-labeled cDNA pools containing 100 cDNAs were incubated with
PIP-beads or control beads and binding assays were carried out as described (Rao et al. 1999). A 34 kDa 35S-labeled protein (arrowhead)
was identified in pool #517 that bound specifically to PIP-beads.
(B) ING2 binds most strongly to PtdIns(5)P. Top, schematic of ING2 domains. Nuclear localization signal (NLS; amino acids 180–200) and
plant homeodomain (PHD; amino acids 200–281) are indicated. Left, schematic of PIP strip lipid blots (Echelon Biosciences). Right, GST-ING2
or GST alone were incubated at 0.5 g/ml with PIP strips. GST-ING2 binds most strongly to PtdIns(5)P (arrow). PE, phosphatidylethanolamine;
PC, phosphatidylcholine; PA, phosphatidic acid; PS, phosphatidylserine.
(C) The PHD finger of ING2 is sufficient for PtdInsP binding. The indicated GST-fusion proteins were tested for binding to PIP strips as in (B).
Caspase-5 (GST-caspase-5 amino acids 82–266); ING2(1–40) (GST-ING2 amino acids 1–40). Arrows indicate the strongest interactions on each
lipid blot.
(D) ING2(PHD) binding to PtdInsPs by SPR. SPR traces of ING2(PHD) binding to the indicated liposomes (4:1 ratio of PC:PtdInsP) coated on L1
pioneer sensor chip. Each mixture was loaded on a separate flow cell between 5000 and 6000 RU (relative units). PC trace was subtracted
for normalization.
(E) IVT ING2(PHD) binds specifically to PtdIns(5)P-affinity resin. 35S-labeled ING2(PHD), p40(PX), or Phish/Dapp1 were incubated with the indicated
PtdInsP-affinity resins and binding assays were carried out as in (A). Input denotes 10% of total IVT protein used for each assay.
(F) Affinity and zinc-dependence of lipid binding by ING2 PHD finger. Left, schematic of “PIP arrays” (Echelon Biosciences) containing the
serial dilutions of the indicated PtdInsPs (in picomoles). The indicated GST-fusions were used to probe PIP arrays as in (B). Arrows indicate
lowest concentration of binding to PtdInsPs by each protein. ING2(PHD-Znmt), the PHD finger of ING2 containing mutations of the zinc coordinating
residues C215S, C217S, C242S, C255S, C258S, H239P, TPEN [N,N,N’,N’-tetrakis(2-pyridyl-methyl)ethylenediamine, Sigma].
Identification of Residues Required for ING2 PHD dicted to occur at the surface of the molecule; (2) the
ING2(PHD-3Kmt) protein behaved like the wild-type proteinFinger-PtdIns(5)P Interactions
To study whether the different basic regions contribute when monitored by fluorescence spectroscopy (data
not shown) (Gaullier et al., 2000); and (3) mutation ofto the ING2 PHD finger-PtdInsPs interaction, we first
mutated the three lysine residues K49, K51, and K53 a tyrosine residue immediately upstream of the lysine
residues (Figure 2B, Y48F) did not affect PtdInsP binding(Figure 2A, red residues) to alanines. Strikingly, this mu-
tation (named “3Kmt”) reduced binding to PtdIns(5)P by (Figure 2C). Thus, as predicted by our structural model,
lysine residues 49, 51, and 53 (designated the 3K motif)8-fold (Figure 2C; see Supplemental Figure S1 available
at http://www.cell.com/cgi/content/full/114/1/99/DC1). are required for the interaction with PtdIns(5)P.
In contrast, lysine residues K58 and R60 were dis-We note that the ING2(PHD-3Kmt) mutant is likely to be folded
properly, since (1) all the amino acid changes are pre- pensable for the PtdInsP interaction (Figure 2C,
Cell
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Figure 2. The PHD Finger Is a General PtdInsP Binding Module that Shares Structural Homology to the FYVE Finger
(A) Superimposition of ING2 PHD finger structural model on the structure of the EEA1 FYVE finger-PtdIns(3)P complex (Kutateladze and
Overduin, 2001). The two domains share the same structural core formed by two Zn-coordination spheres (balls) connected by two strands
of -sheets (ribbons). Pink: model of ING2 PHD finger; light blue: structure of EEA1 FYVE finger; gray: inositol-(1,3)-bisphosphate. Red residues
correspond to (right to left) lysines K49, K51, and K53 and green residues to K58 and R60 of the ING2 PHD finger. Blue residues correspond
to (right to left) arginines R1368, R1370, R1374, and R1399 of EEA1.
(B) Schematic of ING2(PHD) (amino acids 1–81 of the PHD finger) and the indicated mutants.
(C) Identification of basic residues within the ING2 PHD finger that are essential for PtdIns(5)P binding. The indicated GST-fusion proteins
were tested for binding to lipid blots containing serial dilutions of PtdIns(5)P and PtdIns (in picomoles) as in Figure 1.
(D) PHD fingers from diverse proteins bind to PtdInsPs. The indicated GST-fusion proteins were used to probe PIP strips as in Figure 1.
ING1(PHD) (ING1, amino acids 200–279); ACF(PHD), (ATP-dependent chromatin remodeling factor [ACF], amino acids 1131–1211); MLZF(PHD),
(monocytic leukemia zinc finger [MLZF], amino acids 189–336); WSTF(PHD), (Williams-Beuren syndrome transcription factor [WSTF], amino
acids 1174–1254); (AIRE(PHD), autoimmune regulator gene [AIRE], amino acids 300–370); Mi2(PHD), (Mi2, amino acids 367–443). The strongest
interactions on each lipid blot are labeled.
(E) Alignment of the PHD fingers of ING2, ING1, ACF, WSTF, and Mi2. Shaded residues are identical to the ING2 PHD finger. Green boxes:
zinc-coordinating residues. The basic residues between the sixth and seventh zinc-coordinating residues are shown in red, and the basic
residues at the carboxyl end of the PHD fingers in blue. The alignment was generated with MegAlign in the DNASTAR program.
(F) Identification of basic residues in the PHD fingers of ING1 and ACF that are essential for PtdIns(5)P binding. The indicated recombinant
GST-fusion proteins (1 g/ml) were tested for binding to PtdIns(5)P as described in (C).
ING2(PHD-K58A/R60A)). This is also consistent with our model, The PHD Finger Is a General PtdInsP
Binding Modulewhich predicts that these amino acids lie on a different
face of the PHD finger and are not positioned to interact As shown in Figure 2D, several different PHD fingers
from other proteins bind PtdInsPs, but with varying affin-with the PtdInsP head group (Figure 2A).
Finally, we tested whether the basic residues at the ities and specificities. The PHD fingers of ACF and MLZF
bound only to PtdIns(5)P, while the PHD fingers of ING1C-terminal end of the PHD finger (Figure 2E, blue resi-
dues) also function in PtdInsP binding. Binding to and WSTF bound to both PtdIns(3)P and PtdIns(5)P and
that of AIRE bound most strongly to PtdIns(3)P (FigurePtdIns(5)P by these residues alone (Figure 2B, named
Cterm) was barely detectable (Figure 2C). However, both 2D). The binding by MLZF and WSTF was weak, while
Mi2(PHD) did not bind to PtdInsPs at all (Figure 2D). To-truncation of the PHD finger upstream of these residues
(Figure 2B, 64truncmt) and mutation of the basic resi- gether, these data indicate that the PHD finger is a gen-
eral PtdInsP binding domain.dues to alanines (Figure 2B, K72A/K74A/K75A/R77A/
R78A/R80A, named 6K/Rmt) eliminated binding to Figure 2E shows a sequence alignment of several PHD
fingers with varying PtdIns binding profiles. The basicPtdInsPs (Figure 2C; see Supplemental Figure S1). Thus,
the basic residues at the C terminus of the ING2 PHD stretches that are critical for ING2 PHD finger-PtdInsP
interactions (the 3K motif and the basic rich carboxylfinger are necessary but not sufficient for PtdInsP
binding. terminus) are present in other PtdInsP binding PHD fin-
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gers (Figure 2E). Moreover, the number of basic residues alter the levels of these PtdInsPs (Cantley, 2002). As
shown in Figure 3, overexpression of constitutively ac-in these regions correlates with PtdInsP binding
strength. For instance, at the C terminus, the PHD fingers tive PI3K had the predicted effects on the localization
of the GFP-p40(PX), -AKT(PH), and -PLC(PH) fusion proteins.of ING2, ING1, and ACF contain 8, 7, and 6 basic resi-
dues, respectively, whereas the PHD fingers of WSTF In contrast, PI3K expression did not affect the localiza-
tion of GFP-ING2(PHD). We conclude that the localizationand Mi2, have 4 and 1 basic residues, respectively
(Figure 2E, blue residues). of the ING2 PHD finger is influenced by changes in
PtdIns(5)P but not PtdIns(3)P levels.ING1 and ACF both have three basic residues that
are spaced similarly to the ING2 3K motif and located
between the sixth and seventh zinc-coordinating cys- The PHD Finger of ING2 Binds
teines (Figure 2E, red residues). To test whether these Endogenous PtdIns(5)P
residues function in PtdInsP binding, mutant ING1 PHD Next, we asked whether endogenous PtdIns(5)P coim-
finger (K47A, K49A, K51A; ING1(PHD-3Kmt)) and mutant ACF munoprecipitates with the ING2 PHD finger. We used a
PHD finger (R49A, K51A, K53A; ACF(PHD-3K/Rmt)) were gen- construct encoding three tandem repeats of the ING2
erated (Figure 2F). Similar to the ING2(PHD-3Kmt) mutant, PHD finger (PHDX3), which binds to PtdIns(5)P in vitro
both the ING1(PHD-3Kmt) and ACF(PHD-3K/Rmt) mutant proteins (Figure 4A). 293 cells were transfected with GFP, GFP-
had greatly reduced affinity for PtdIns(5)P (Figure 2F). PX, or GFP-PHDX3 and the overexpressed protein im-
These data suggest that the general structural basis for munoprecipitated. Western analysis confirmed equal
PtdInsP binding by different PHD fingers is conserved. expression of the transfected proteins (Figure 4B). Total
lipid in each immunoprecipitate (IP) was recovered and
in vitro phosphorylated with the lipid kinases PIKIIn Vivo Recruitment of the ING2 PHD Finger to
(which phosphorylates PtdIns(4)P) or PIKII (whichPtdIns(5)P Generated at the Plasma Membrane
phosphorylates PtdIns(3)P or PtdIns(5)P) to determineby the Lipid Phosphatase IpgD
the relative quantity of monophosphorylated PtdInsPWe next addressed whether the ING2 PHD finger can
species in each sample (Clarke et al., 2001).interact with PtdInsPs under physiologic conditions in
Total cell lysates contained10 times more substratevivo. The PX domain of p40phox (p40(PX)), a highly spe-
for PIKI (PtdIns(4)P) than PIKII (PtdIns(3)P andcific marker for PtdIns(3)P (Ellson et al., 2001; Kanai
PtdIns(5)P) (Figure 4C), consistent with published re-et al., 2001), showed no significant colocalization with
ports (Payrastre et al., 2001). The same ratio was ob-ING2(PHD) (data not shown), arguing against PtdIns(3)P
served for the control (GFP) IP, likely reflecting nonspe-being a major ligand of ING2(PHD) (see below).
cific binding of cellular PtdInsPs to GFP (Figures 4DSimilar in vivo localization studies of PtdIns(5)P have
and 4E). In contrast, both the PHDX3 and the PX IPsnot been possible due to the lack of known PtdIns(5)P
contained greater amounts of PIKII substrate (Figurebinding proteins. Recently, the bacterial protein IpgD
4D) relative to PIKI substrate (Figure 4E), indicatingwas shown to dephosphorylate PtdIns(4,5)P2 and con-
specific PtdIns(3)P/PtdIns(5)P enrichment. However, wevert it into PtdIns(5)P at the plasma membrane (Niebuhr
note that we cannot distinguish whether these interac-et al., 2002). To study colocalization with PtdIns(5)P, we
tions are established before or after cell lysis.asked whether generation of PtdIns(5)P at the plasma
membrane upon expression of IpgD can specifically re-
cruit the ING2 PHD finger to the plasma membrane. PIKII Alters the Subcellular Localization
of Endogenous ING2Various GFP-fusion proteins were expressed in the pres-
ence or absence of IpgD and their subcellular localiza- To determine whether the localization of endogenous
ING2 is regulated by PtdIns(5)P, we generated a rattion determined. In the absence of IpgD, there is intense
nuclear GFP-ING2(PHD) signal as well as weaker, diffuse polyclonal anti-ING2 antibody. This antibody stains the
nucleus (Figure 5A) and detects multiple bright nuclearcytoplasmic signal (Figure 3). In the presence of IpgD,
there is recruitment of GFP-ING2(PHD) to sections of the foci (see Figure 5B, column I). In addition, there is faint
cytoplasmic staining. This antibody is specific for ING2plasma membrane and loss of the diffuse cytoplasmic
distribution (Figure 3; see Supplemental Figure S2). This protein, as knockdown of endogenous ING2 levels with
RNA interference (RNAi) (Brummelkamp et al., 2002) com-effect of IpgD requires an intact PHD finger, since the
GFP-ING2(PHD-Znmt) and GFP-ING2(PHD-3Kmt) mutants are un- pletely eliminated the nuclear signal and reduced the cyto-
plasmic signal (Figure 5A, column V; see Figure 6).affected by IpgD expression (Figure 3). IpgD activity
was robust in our system, as its expression caused a PIKII has been shown to utilize PtdIns(5) as a sub-
strate to generate PtdIns(4,5)P2 in vitro (Rameh et al.,significant shift in the localization of PLC(PH) (which
binds PtdIns(4,5)P2) from the plasma membrane to the 1997). We found that overexpression of PIKII altered
ING2 subcellular localization in vivo (Figure 5A, panelcytoplasm (Figure 3), consistent with a reduction of
PtdIns(4,5)P2 levels at the plasma membrane (Niebuhr II). Specifically, the ING2 signal became stronger in the
cytoplasm than the nucleus, and the ING2 nuclear fociet al., 2002). Moreover, the IpgD activity is specific for
changes in PtdIns(4,5)P2 and PtdIns(5)P levels, since were fewer and less intense than in control cells (Figures
5A and 5B, panels I and II). We note that the overex-the localization of p40(PX) and AKT(PH) (which binds
PtdIns(3,4,5)P3; James et al., 1996) were minimally af- pressed PIKII accesses the nucleus (Figure 5C).
A recent study identified ING2 as a nonstoichiometricfected by IpgD expression (Figure 3).
PI3K generates PtdIns(3)P from PtdInsP, and component of the human mSin3a-HDAC complexes,
suggesting that ING2 associates with chromatin (Kuzmi-PtdIns(3,4,5)P3 from PtdIns(4,5)P2 and can be used to
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Figure 3. Recruitment of GFP-PHD Finger to
the Plasma Membrane via IpgD-Mediated
Generation of PtdIns(5)P
Confocal images of HT1080 cells cotransfected
with the indicated plasmids. GFP fusion pro-
teins: ING2(PHD); ING2(PHD-Znmt; ING2(PHD-3Kmt);
p40(px),; PLC(PH), PH domain of PLC ; AKT(PH),
PH domain AKT/PKB. I, control; II, IpgD; and
III, PI3K. The percent representation of the
images is indicated in the upper right corner.
chev et al., 2002). To detect the chromatin-associated chromatin and the nuclear matrix remain (Mirzoeva and
Petrini, 2001). As shown in Figure 5B, after in situ frac-pool of ING2, we carried out in situ fractionation of
HT1080 cells prior to immunostaining with anti-ING2 tionation, detergent-resistant ING2 remains detectable
in the nucleus and nuclear foci, indicating associationantibody (Figures 5A and 5B, panels III and IV). In this
method, nucleoplasmic proteins are detergent- with chromatin and the nuclear matrix. Strikingly, the
detergent-resistant ING2 nuclear signal is selectivelyextracted, and only proteins tightly associated with
Figure 4. The PHD Finger of ING2 Binds En-
dogenous PtdInsPs
(A) Triple repeat of the ING2 PHD domain
binds tightly to PtdIns(5)P in vitro. GST-
PHDX3 was used to probe PIP arrays as in
Figure 2. Arrowhead indicates lowest con-
centration of PtdIns(5)P binding detected.
(B) Western analysis demonstrates equal ex-
ogenous protein expression. Anti-GFP IPs of
HEK293 cells transfected with the indicated
plasmids (control, GFP; PX, GFP-PX; PHDX3,
GFP-PHDX3) and immunoblotted with anti-
GFP antibody. Arrows indicate the overex-
pressed proteins. IgG, immunoglobulin heavy
chain.
(C) Activity of PIKI and PIKII on whole-cell
extracts. In vitro lipid kinase assays using
PIKI and PIKII were performed on total
HEK293 cell lysate.
(D) PHDX3 coimmunoprecipitates endoge-
nous PtdIns(5)P and/or PtdIns(3)P. PIKII
lipid kinase was used to in vitro phosphory-
late lipids isolated in IPs of HEK293 cells
transfected with the indicated plasmids.
Arrow indicates the product of PIKII activity.
(E) Specific coimmunoprecipitation of PHDX3 and endogenous PtdIns(5)P and/or PtdIns(3)P. Lipid kinase assays using PIKI were carried out
as in (C). Arrow indicates product of PIKI activity.
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Figure 5. PIKII Regulates the Subcellular
Localization of Endogenous ING2 Protein
(A) PIKII expression decreases endogenous
ING2 nuclear signal. HT1080 cells were
stained with anti-ING2 antibody (green) and
To-Pro-3 nuclear dye (blue). I, control trans-
fection (pCDNA3); II, PIKII transfections; III,
control transfection with triton treatment; IV,
PIKII transfection with triton treatment; and
V, ING2 RNAi-transduced cells. Representa-
tive images are shown.
(B) High magnification (250) view of nuclei
in (A).
(C) Overexpressed PIKII is found in the nu-
cleus. I, anti-PIKII (green); II, To-Pro-3 (blue);
III, merge of I and II.
(D) Western blot analysis of indicated cellular
fractions after PIKIIoverexpression. HT1080
cells were transfected with control (pCDNA3)
or PIKII prior to biochemical separation into
cytosolic (lanes 1–2), nucleoplasmic (lanes
3–4), and chromatin-enriched/nuclear matrix
(lanes 5–6) fractions. Western antibodies are
indicated at left.
(E) Quantitation of ING2 expression levels in
fractionated HT1080 cells / PIKII trans-
fection as in (D). Results represent the
mean  SEM of three independent experi-
ments.
(F) Total ING2 levels are not altered by PIKII
overexpression. Whole-cell extracts of HT1080
cells transfected with either control (pCDNA3)
or PIKII and probed with the indicated anti-
bodies.
eliminated in cells overexpressing PIKII, suggesting ING2 overexpression stimulates acetylation of p53 and
induces apoptosis (Nagashima et al., 2001). To testthat reducing nuclear PtdIns(5)P levels with PIKII re-
duces ING2-association with chromatin/nuclear matrix whether these effects are dependent on the lipid binding
activity of ING2, we assessed p53 acetylation levels and(Figure 5B, compare panels III and IV). We note that
as controls, this in situ fractionation method gave the cell death in response to overexpression of full-length
wild-type ING2 or two different mutants, ING2(Znmt) andexpected histone H3 and BRCA1 signals (data not shown).
We also analyzed the effect of PIKII on ING2 subcel- ING2(3Kmt), whose PHD fingers are defective in lipid bind-
ing in vitro (Figures 1F and 2C; data not shown). Aslular distribution by biochemical fractionation. HT1080
cells were separated into cytoplasmic, nucleoplasmic, shown in Figure 6A, p53 acetylation levels were in-
creased upon overexpression of wild-type ING2 but notand chromatin-enriched/nuclear matrix fractions (Men-
dez and Stillman, 2000) (Figure 5D). In control cells, the ING2(Znmt) and ING2(3Kmt) mutants, despite equal levels
of the overexpressed proteins. Total p53 levels were theendogenous ING2 was detected primarily in the chroma-
tin/nuclear matrix fraction (Figure 5D). Overexpression same in all samples. The p53-response gene p21 was
also upregulated by wild-type ING2 but not by the mu-of PIKII decreased the levels of ING2 in this fraction,
and increased ING2 levels in the other two fractions tant proteins (Figure 6A).
Further, the ING2(Znmt) and ING2(3Kmt) mutants were also(Figure 5D; quantitated in 5E).
As controls for the quality of the biochemical fraction- defective in inducing cell death (Figure 6B). This inability
of ING2(Znmt) and ING2(3Kmt) to induce p53 acetylation andation and protein sample loading, the cytosolic protein
caspase-9 and histone H4 are detected only in the ex- apoptosis is unlikely due to a general disruption of ING2
protein structure, since both IVT mutant proteins, likepected fractions, and HDAC1 is detected in all three
fractions (Figure 5D). PIKII overexpression did not wild-type IVT ING2, interacted with GST-ING2, but a
control protein (IVT PIAS1) did not (Figure 6C). Thesechange total ING2 protein levels (Figure 5F). Together,
the data indicate that PIKII overexpression releases data argue that mutations within the PHD domain do
not disrupt the overall structure of the ING2 protein andING2 protein from chromatin (see Discussion).
indicate that the ability of overexpressed ING2 to induce
p53 activation and apoptosis requires the PtdInsP bind-ING2 Function Requires an Intact PtdInsP
Binding Domain ing activity of the PHD finger of ING2.
Next, we asked whether the effect of ING2 on apopto-To elucidate the functional significance of the interaction
between the ING2 PHD finger and PtdInsPs, we asked sis is directly dependent on p53. To this end, p53 protein
was knocked down in HT1080 cells (which have normalif ING2 activity is compromised by mutations that disrupt
binding to PtdIns(5)P. Previous studies reported that p53 responses) by RNAi (Figure 6D) and the activity of
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Figure 6. ING2 Induces p53-Dependent Apo-
ptosis
(A) The ability of overexpressed ING2 to in-
duce p53 acetylation and p21 protein expres-
sion levels requires an intact PHD finger.
Western analysis of HT1080 cells transfected
with the indicated plasmids. Antibodies used
are indicated.
(B) The ability of overexpressed ING2 to in-
duce apoptosis requires an intact PHD finger.
Cell death was measured by propidium iodine
exclusion in HT1080 cells transfected with 10
g of the indicated plasmids.
(C) Mutations that disrupt PtdInsP binding do
not affect the ability of ING2 to homodimerize.
GST-pull downs of 35S-labeled IVT ING2,
ING2(Znmt), ING2(3Kmt), or control protein (PIAS1)
incubated with either GST or GST-ING2 affin-
ity resins. Input denotes 20% of total IVT pro-
tein used for each assay.
(D) RNAi knockdown of endogenous p53.
Western analysis of whole-cell extracts from
either control RNAi or p53 RNAi-treated
HT1080 cells transfected with 10g of pCDNA3
vector, ING2, or ING2(3Kmt). Antibodies are indi-
cated.
(E) ING2-induced apoptosis requires endoge-
nous p53. Cell death was determined in control
RNAi or p53 RNAi-treated HT1080 cells trans-
fected with the indicated plasmids as in (D).
(F) RNAi knockdown of endogenous ING2. Western analysis of whole-cell extracts from either control RNAi or ING2 RNAi-treated HT1080 cells
that were incubated for 24 hr with vehicle control (DMSO) or 100 M etoposide. Antibodies are indicated.
(G) RNAi-mediated knockdown of ING2 renders HT1080 cells resistant to p53-mediated apoptosis. Cell death was determined in control RNAi
or ING2 RNAi-treated HT1080 cells 24 hr after incubation with either vehicle (DMSO), etoposide (100 M), hydrogen peroxide (25 M) or Fas
ligand (5 ng/ml)  cyclohexamide (1 g/ml). All cell death results represent the mean  SEM from at least three independent experiments.
ING2 in these cells was determined. As shown in Fig- GFP-PHDX3, a high avidity PtdInsP binding module (Fig-
ure 4), might function as a dominant negative of ING2ures 6D and 6E, ING2 overexpression failed to induce
p21 protein and apoptosis in p53-RNAi-treated cells, activity by competing for endogenous PtdIns(5)P. In-
deed, overexpression of this fusion protein significantlydemonstrating that ING2-mediated apoptosis is p53-
dependent. reduced etoposide-induced apoptosis (Figure 7A). In
contrast, overexpression of GFP-PHD(Znmt)X3, a con-
struct encoding three tandem repeats of the zinc-chela-RNAi-Mediated ING2 Knockdown Renders Cells
Resistant to Cell Death Stimuli tion mutant PHD finger, had no effect on etoposide-
induced apoptosis (Figure 7A). In addition, the moreTo determine whether endogenous ING2 functions in
cell death responses, we used RNAi to knock down subtle 3Kmt mutation, which specifically targets
PtdIns(5)P binding, also lacked dominant-negative ac-ING2 protein in HT1080 cells. ING2 RNAi-treatment dra-
matically and specifically reduced ING2 protein levels tivity (GFP-PHD(3Kmt)X3, see Figure 2), and did not in-
relative to control RNAi-treated cells (Figure 6F). ING2 terfere with etoposide-induced apoptosis (Figure 7A).
RNAi-treated cells were highly resistant to apoptosis Next, we used a different PtdIns(5)P binding PHD fin-
induced by etoposide and hydrogen peroxide treat- ger from a heterologous protein, ACF, which binds in
ments (Figure 6G). In contrast, p53-independent Fas vitro to PtdIns(5)P with nearly the same affinity as the
ligand-induced apoptosis was unaffected by ING2 ING2 PHD finger (see Figure 2). GFP-ACF(PHDX3) (triple
RNAi-treatment (Figure 6G). repeat of the ACF PHD finger) protected cells from eto-
Etoposide treatment of HT1080 cells induces p53 poside-induced apoptosis nearly as well as PHDX3 (Fig-
acetylation and expression of p21 (Figure 6F). In ING2 ure 7A). In contrast, Fas-ligand induced apoptosis was
RNAi-treated cells, both these effects were significantly unaffected by the PHDX3 and ACF(PHD)X3 fusions.
reduced (Figure 6F; for quantitation see Supplemental Overexpression of the PHDX3 and ACF(PHD)X3
Figure S3). Loss of ING2 had no effect on baseline p21 PtdInsP binding modules also inhibited etoposide-
levels or etoposide-induced increases in total p53 levels mediated acetylation of p53 and p21 protein induction
(Figure 6F). We conclude that in HT1080 cells, endoge- compared to GFP control, PHD(Znmt)X3 and
nous ING2 protein plays a critical role in p53-regulated PHD(3Kmt)X3 (Figure 7B; for quantitation see Supple-
apoptotic pathways. mental Figure S3). We note that the different GFP fusion
proteins were expressed at similar levels, though GFP
alone protein was expressed significantly better (theThe Isolated PHD Finger Has Dominant-Negative
Activity on ING2 Function difference in expression was not due to differential
transfection efficiency, see Experimental Procedures;We next explored whether PtdIns(5)P is required for
ING2 function. We reasoned that overexpression of Figure 7B). Together, our data argue that the triple tan-
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Figure 7. ING2 Function Requires Its PtdInsP Binding Activity and Is Inhibited by PIKII
(A) Isolated PHD finger inhibits etoposide-induced cell death. Cell death was determined in HT1080 cells transfected with 10 g of the indicated
plasmids and treated with vehicle (DMSO), etoposide (100 M), or Fas ligand (5 ng/ml) and cyclohexamide (1 g/ml) for 24 hr.
(B) Isolated PHD finger inhibits etoposide-mediated induction of p53 acetylation and p21 protein expression. Western analysis of H1080 cells
transfected with 10 g of the indicated plasmids and treated with etoposide (100 M) for 24 hr. Arrows indicate the overexpressed GFP fusion
proteins.
(C) Requirement of ING2 for the ability of the isolated PHD finger to inhibit etoposide-mediated cell death. Cell death was determined in
control RNAi or ING2 RNAi-treated HT1080 cells transfected with 10 g of the indicated plasmids.
(D) Reconstitution of ING2 biochemical activity requires PtdInsP binding. Western analysis of control RNAi (lane 1) or ING2 RNAi(lanes 2–5)-
treated cells transfected with 2 g of the indicated plasmids and incubated with 100 M etoposide for 24 hr. The control RNAi cells were
transfected with 2 g of vector control (pCDNA3).
(E) Reconstitution of ING2 apoptosis activity requires PtdInsP binding. Cell death was determined in cells treated as in (D).
(F) PIKII expression inhibits ING2-mediated p53 acetylation and p21 protein induction. Western analysis of whole-cell extracts of HT1080
cells transfected with 10 g total of each plasmid pair (vector, PIKII, or ING2). Antibodies are indicated.
(G) PIKII expression inhibits ING2-mediated apoptosis. Cell death was determined in cells treated as in (F).
(H) PIKII inhibits doxorubicin-induced p53 acetylation in an ING2-dependent manner. Western analysis of control RNAi or ING2 RNAi-treated
HT1080 cells transfected with vector control (pCDNA3) or PIKII and incubated with of 1 M doxorubicin for 16 hr. Antibodies are indicated.
(I) PIKII inhibits doxorubicin-induced apoptosis in an ING2-dependent manner. Cell death was determined in cells as in (H). All cell death
results represent the mean  SEM from at least three independent experiments.
dem PHD finger modules of ING2 and ACF inhibit etopo- whether the GFP-PHDX3 module protects cells against
etoposide-induced apoptosis when ING2 expression isside-induced apoptosis in HT1080 cells by sequestering
PtdIns(5)P from target proteins such as ING2. decreased with RNAi. As shown in Figure 7C, the differ-
ence in protection between GFP-PHDX3 and GFP con-To determine whether the dominant-negative effect
of the PHD modules is dependent on ING2, we asked trol in ING2 RNAi-treated cells was not statistically sig-
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nificant, in contrast to control RNAi cells (Figure 7C). conclusion that the PHD finger is a PtdInsP binding
domain is consistent with observations that the PHDThus, a considerable fraction of the protective effects
of the GFP-PHDX3 module can be attributed to interfer- finger of the WSTF protein is structurally similar to the
FYVE-finger, a PtdIns(3)P binding module (Misra et al.,ence with ING2 function, although other PtdIns(5)P-
dependent proteins may also be affected. 2001; Pascual et al., 2000). Based on structural modeling
and mutational analysis, we have identified two basic
patches that are essential for PtdIns(5)P-ING2 PHD fin-Reconstitution of ING2 Activity after RNAi-Mediated
ger interactions (Figure 2). We propose that these twoKnockdown of ING2 Requires PtdInsP
patches are located on the same surface and contactBinding Activity
the inositol head group of PtdIns(5)P.To test the functional significance of ING2-PtdInsP inter-
actions by an independent approach, we attempted to
reconstitute ING2 activity in the ING2 RNAi-treated cells PtdIns(5)P as a Physiologic Ligand of ING2
with exogenous ING2 or ING2 PtdInsP binding mutants. The existence of PtdIns(5)P as a cellular PtdInsP species
To avoid RNAi mediated degradation of exogenous was clearly established only a few years ago (Rameh et
ING2, murine ING2 (mING2) was used for reconstitution. al., 1997). Since then, PtdIns(5)P levels have been shown
ING2 RNAi-treated cells were transfected with low to undergo dynamic fluctuations in response to regula-
amounts of mING2, mING2(Znmt), mING2(3Kmt) expression tory signals (Morris et al., 2000; Schaletzky et al., 2003)
vectors or vector control. The different ING2 constructs and increase 20-fold in the nucleus during G1 in cycling
reconstituted ING2 protein levels in the ING2 RNAi- cells (Clarke et al., 2001). A specific function for
treated cells to levels slightly higher than control RNAi- PtdIns(5)P, however, has not been previously described.
treated cells (Figure 7D). Notably, reconstitution with Our in vitro data suggest that the preferred substrate
wild-type mING2, but not mING2(Znmt) or mING2(3Kmt), re- for the PHD finger of ING2 is PtdIns(5)P. However, since
stored etoposide-induced p53 acetylation and p21 pro- in vivo, PtdIns(4)P is 20-fold more abundant than
tein expression to the levels seen in the HT1080 control PtdIns(5)P (Payrastre et al., 2001), it is not possible to
RNAi-treated cells, whereas total p53 and tubulin levels determine which PtdInsP species is the physiologic li-
are the same for all samples (Figure 7D; for quantitation gand of ING2 without studying the interaction in a physi-
see Supplemental Figure S3). Finally, wild-type mING2, ologic context. The ING2 PHD finger does not colocalize
but not the mING2 mutants, resensitized the ING2 RNAi- in vivo with any known PtdInsP-markers and is not af-
treated cells to etoposide-induced apoptosis (Figure fected by PI3K or wortmannin (Figure 3; data not shown).
7E). Together, these data argue that the ability of ING2 To examine in vivo interaction with PtdIns(5)P, we uti-
to bind to PtdInsPs is critical for its in vivo function in lized the recently discovered bacterial inositol-4-phos-
p53-dependent cell death pathways. phatase IpgD (Figure 3) (Niebuhr et al., 2002). By overex-
pressing IpgD, we demonstrate specific recruitment of
the PHD finger of ING2 to the plasma membrane. ThisPIKII Inhibits ING2 Activity
is likely due to in vivo colocalization between ING2 PHDTo test whether alterations of endogenous PtdIns(5)P
finger and newly synthesized PtdIns(5)P at the plasmalevels affect ING2 function, we tested the consequence
membrane (Figure 3) (Niebuhr et al., 2002). Further, weof PIKII overexpression on activities regulated by ING2.
provide biochemical evidence that the PHD finger co-IPsIn cells overexpressing PIKII, the ability of ING2 to
endogenous PtdIns(5)P or PtdIns(3)P but not PtdIns(4)Pinduce p53 acetylation, p21 protein and apoptosis were
(Figure 4). Together, the data demonstrate that PtdIns(5)Psignificantly diminished (50%) (Figures 7F and 7G; for
is the preferred binding partner of the ING2 PHD fingerquantitation see Supplemental Figure S3). These results
both in vitro and in vivo.suggest that decreasing endogenous PtdIns(5)P levels
Both PtdIns(5)P and PIKII have been reported toinhibit ING2 function.
exist and function in the nucleus (Boronenkov et al.,To test whether PtdIns(5)P can regulate physiologic
1998; Clarke et al., 2001; Rameh et al., 1997). To addressapoptotic stimuli, we examined the effects of PIKII
whether endogenous PtdIns(5)P and endogenous ING2overexpression on doxorubicin-induced p53 acetylation
interact, we overexpressed PIKII and show that theand apoptosis. As shown in Figures 7H and 7I, doxorubi-
association of ING2 with chromatin/nuclear matrix iscin-induced p53 acetylation levels and apoptosis were
weakened (Figure 5). We therefore propose that the as-both significantly reduced (quantitation of acetylation
sociation of ING2 with chromatin is regulated by bindingsee Supplemental Figure S3). These effects were absent
to PtdIns(5)P (see below).in ING2 RNAi-treated cells, suggesting that the prosur-
vival function of overexpressed PIKII requires ING2
protein to be present. Physiologic Role of ING2-PtdInsP Signaling
Previous studies showed that ING2 expression is upreg-
ulated by DNA damaging agents, and that overexpres-Discussion
sion of ING2 leads to p53 acetylation and apoptosis
(Nagashima et al., 2001). Consistent with this, we findThe PHD Finger of ING2 Is a PtdInsP
Binding Module that endogenous ING2 is critical for efficient p53 acetyla-
tion, p21 protein induction, and cell death following DNAIn our screen of 100,000 proteins, ING2 was identified
as one of twelve candidate PtdInsP binding proteins damage treatments (Figure 7). Notably, these functions
are abrogated by mutations in the PHD finger that spe-(Figure 1A; data not shown). We have shown by three
independent in vitro assays that the PHD finger of ING2 cifically interfere with PtdIns(5)P binding or by PIKII
overexpression, which should decrease endogenousis sufficient for interaction with PtdInsPs (Figure 1). Our
ING2 PHD Finger as a Nuclear PtdInsP Receptor
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PtdIns(5)P stores. ING2 has been shown to copurify with General Function of PHD Fingers
In addition to the PHD finger of ING2, we have foundthe human Sin3a-histone deacetylase complex (Kuzmi-
chev et al., 2002). Other ING proteins, including ING1, that PHD fingers from different chromatin-associated
factors bind to PtdInsPs (Figure 2D), suggesting thatand the fission yeast homologs, Yng1 and Yng2 have
been shown to associate with and modulate the activity PHD fingers might function as general nuclear PtdInsP-
receptors. Recent work proposed that some putativeof HAT complexes (Feng et al., 2002). Thus, the ability
of ING2 to modulate acetylation levels may be through PHD finger domains function as cytoplasmic E3-ubiqui-
tin ligases (reviewed in Coscoy and Ganem, 2003), butregulating the activity of coactivator and/or corepressor
complexes. Our data indicate that PtdInsPs can modu- other analyses indicate that these domains are RING
fingers and not bona fide PHD fingers (Aravind et al.,late this function of ING2.
We would like to suggest that the mechanism by which 2003). We have not found any auto-E3-ubiquitin ligase
activity for the ING2 PHD finger, but have found thatPtdInsPs regulate ING2 function could be highly analo-
gous to the mechanism of AKT/PKB activation by the MEKK1 PHD finger, which has E3-ubiquitin ligase
activity (Lu et al., 2002), binds weakly to PtdInsPs (O.G.PtdIns(3,4,5)P3 (Vanhaesebroeck and Alessi, 2000). In
the case of AKT/PKB, generation of PtdIns(3,4,5)P3 at and J.Y., unpublished data).
the plasma membrane in response to extracellular stim-
uli recruits AKT/PKB and allosterically activates its ki- Function of PtdInsPs in the Nucleus
nase activity (Franke et al., 1997). Because previous We would like to speculate that PtdInsP-PHD finger
studies detected PtdInsPs in association with chromatin interactions might have broad roles in regulating nuclear
(Irvine, 2000), and our data indicate that a significant processes. Evidence for this is the large number of nu-
portion of nuclear ING2 cofractionates with chromatin, clear proteins (over 100) that contain PHD fingers, and
one possibility is that chromatin bound PtdInsPs func- our demonstration that a significant number of the PHD
tion to either recruit or stabilize ING2 at chromatin. This fingers we tested had detectable PtdInsPs binding activ-
interaction may also lead to allosteric activation of ING2. ity. The ability of PtdInsPs to undergo rapid alterations in
Both these possibilities are consistent with our finding species and mass in a temporally and spatially regulated
that mutations in ING2 that abrogate PtdInsP binding manner within the nucleus makes them ideal molecular
disrupt the function of ING2, and that overexpression modulators of processes like transcriptional activation,
of the isolated PHD finger has dominant-negative effects DNA repair, and recombination. In this study, we have
on ING2 functions (Figure 7). Taken together, the data shown one example whereby PtdInsPs modulate p53
suggest that the generation of PtdInsPs at specific chro- activity and cell death via interactions with ING2. Our
matin locations could lead to localized activation of ING2. observations further strengthen the argument that the
function of PtdInsPs in the nucleus may be as diverse
Inositol Polyphosphates as Potential Ligands of ING2 as their roles in cytoplasmic processes.
In contrast to PtdInsPs, the role of inositol polyphos-
phates (IP) in nuclear function is more established (York Experimental Procedures
et al., 2001). In mammalian cells, inositol hexakisphos-
Materialsphate (IP6) may regulate nonhomologous end-joining
PtdInsPs are from Echelon Biosciences, Inc. (Salt Lake City, Utah).through binding to Ku70/80 (Hanakahi and West, 2002;
Antibodies: Rat polyclonal anti-ING2 was generated against full-
Ma and Lieber, 2002). In budding yeast, it has recently length ING2; antiacetyl-p53(320 and 373), antitubulin, and anti-
been shown that at high concentrations, inositol tetra- HDAC1 (Upstate Biotechnology); antiacetyl-p53(382) (from S. Saito
and pentakisphosphate (IP4 and IP5, respectively) and and E. Appella); anti-p53 (Ab-6) and anti-p21 (AB-1) (Oncogene Re-
search); and anti-PIKII (Santa Cruz).IP6 can modify nucleosome remodeling in an in vitro
system (Shen et al., 2003). In addition, Arg82/IPK2, an
Cell-Culture Assays and RNAiinositol phosphate kinase, is needed for efficient recruit-
Transfections were carried out using LT1 (Mirus). Expression of GFPment of chromatin remodeling complexes to the PHO5
was used to monitor transfection efficiency. ING2-specific RNAipromoter (Steger et al., 2003). Interestingly, another pro-
transfection vectors generated with pSuper as described (Brummel-
tein that was shown to genetically regulate PHO5 tran- kamp et al., 2002). Control RNAi contained sequence with no homol-
scriptional activation is PHO23 (Lau et al., 1998), a mem- ogy to any human genes. HT1080 cells were assayed 60–72 hr after
ber of the ING family, bringing up the intriguing transfection of the RNAi vectors. Retroviral RNAi constructs were
generated by cloning from pSuper into pBabe (ING2) or pQCXINpossibilities that PHO23 directly binds IPs or that Arg82/
(Clontech) (for p53). Infected HT1080 cells were assayed after 2IPK2 may modify PtdInsP metabolism in the nucleus.
days of puromycin selection. Cell death was determined by propid-We have investigated whether the PHD finger of ING2
ium iodine staining followed by sub-G1 determination or MTS assays
binds to IPs. Indeed, inositol-(1,5)-bisphosphate (IP(1,5)), (Promega) as previously described (Degterev et al., 2001).
but not IP(1,4), IP3, or IP4, binds to the PHD finger of
ING2; however, this binding is 2 orders of magnitude PtdInsP Binding Assays and In Vitro Lipid Kinase Assays
weaker than PtdIns(5)P binding (O.G. and J.Y., unpub- Small pool expression screen was carried out using a murine spleen
cDNA library and an affinity resin designed to emulate PtdInsPs aslished data). These results suggest that the products of
previously described (Rao et al., 1999). Protein lipid-blot assays,Arg82/IPK2 (IP4 and IP5) do not regulate ING2 function
SPR and PtdInsP-affinity resin pulldowns were carried out as de-in mammalian cells. To the best of our knowledge, the
scribed (Dowler et al., 2002; Rao et al., 1999; Santagata et al., 2001).existence of IP(1,5) in cells has not been reported; how- In vitro lipid kinase assays: 293 cells transfected with GFP-fusion
ever, it is nevertheless possible that IP(1,5) is a physiologic constructs were lysed/IPed in 50 mM Tris [pH 8], 50 mM KCl, 10 mM
ligand of ING2, perhaps through competing for binding EDTA, 1% NP40, NaF 15 mM, orthovanadate 1 mM, and protease
inhibitor cocktail (Roche). Ten percent of the IP was used for westernwith PtdIns(5)P.
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blots. The remaining 90% of the IP was subjected to lipid extraction Mitchison, T., and Yuan, J. (2001). Identification of small-molecule
inhibitors of interaction between the BH3 domain and Bcl-xL. Nat.and assayed as described (Clarke et al., 2001).
Cell Biol. 3, 173–182.
Western Analysis, In Situ, and Biochemical Fractionation Dowler, S., Currie, R.A., Campbell, D.G., Deak, M., Kular, G., Downes,
p53 acetylation assays were carried out as described (Saito et al., C.P., and Alessi, D.R. (2000). Identification of pleckstrin-homology-
2002). In situ fractionation was carried out essentially as described domain-containing proteins with novel phosphoinositide-binding
(Mirzoeva and Petrini, 2001), except that cells were lysed in: PBS specificities. Biochem. J. 351, 19–31.
[pH 7.4], 10% w/v Sucrose, and 0.2% triton. Rat anti-ING2 was used Dowler, S., Kular, G., and Alessi, D. (2002). Protein lipid overlay
at 1:100. Biochemical fractionation was carried out as described assay. Science’s STKE http://stke.sciencemag.org/cgi/content/full/
(Mendez and Stillman, 2000). OC_sigtrans;2002/129/pl6.
Ellson, C.D., Gobert-Gosse, S., Anderson, K.E., Davidson, K., Erdju-
Homology Modeling
ment-Bromage, H., Tempst, P., Thuring, J.W., Cooper, M.A., Lim,
Comparative models of human ING2 protein (residues 200–264) were
Z.Y., Holmes, A.B., et al. (2001). PtdIns(3)P regulates the neutrophil
built based on the solution structures of human WSTF and KAP-1
oxidase complex by binding to the PX domain of p40(phox). Nat.
proteins (Capili et al., 2001; Pascual et al., 2000) using the MODELER
Cell Biol. 3, 679–682.
and CHARMM programs and validated using the program ProsaII
Feng, X., Hara, Y., and Riabowol, K. (2002). Different HATS of the(Sali and Blundell, 1993). Superposition of the modeled ING2 PHD
ING1 gene family. Trends Cell Biol. 12, 532–538.structure on the known structure of EEA1 FYVE finger-Inositol (1,3)
Franke, T.F., Kaplan, D.R., Cantley, L.C., and Toker, A. (1997). Directbisphosphate complex (Kutateladze and Overduin, 2001) is the re-
regulation of the Akt proto-oncogene product by phosphatidylinosi-sult of the best backbone RMSD fit of the structurally homologous
tol-3,4-bisphosphate. Science 275, 665–668.N-terminal portions of the two domains (residues 13–28 and 35–39
of ING2 PHD finger; residues 12–27 and 32–36 in EEA1 FYVE finger). Fyodorov, D.V., and Kadonaga, J.T. (2002). Binding of Acf1 to DNA
involves a WAC motif and is important for ACF-mediated chromatin
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